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Abstract Phosphatidyl inositol 3-kinase (PI3K) plays an essen- 
tial role in numerous ignaling events, and increasingly has been 
implicated in regulation of certain membrane traffic events. The 
polymeric immunoglobulin receptor (pIgR) transcytoses dimeric 
IgA (dIgA) across epithelial ceils and into external secretions, 
where the dIgA forms the first specific immunological defense 
against infection. We show here that wortmannin, a highly spe- 
chic inhibitor of PI3K, inhibits transcytosis of dIgA by the plgR. 
Instead, the dIgA is recycled back to the basolateral surface of 
the epithelial cell. PI3K therefore plays an essential role in regu- 
lating the transcytosis of dIgA, a key step in the mucosal immune 
response. 
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1. Introduction 
Phosphatidylinositol 3-kinase (PI3K) is a family of enzymes 
that catalyzes the phosphorylation f phosphatidylinositols n 
the 3' position of the inositol ring [1]. This enzyme and its 
products have been implicated in a wide variety of intracellular 
signaling events. In the last two years there has been particular 
interest in the possible role(s) of PI3K in regulation of mem- 
brane traffic. The seminal observation in this field was the 
discovery that a PI3K plays a vital role in sorting of vacuolar 
enzymes in the yeast, Saccharomyces cerevisiae. Mutations of 
the VPS34 gene inhibit delivery of newly made vacuolar en- 
zymes from the trans-golgi network (TGN) to an endosomal 
compartment and then to the vacuole [24]. The newly-made 
vacuolar enzymes are instead mistargeted and secreted from the 
cell. These mutations also cause a profound decrease in PI3K 
activity in yeast. The VPS34 gene was found to encode a pro- 
tein with significant sequence similarity to the catalytic subunit 
(p110) of a mammalian PI3K. 
The role of PI3K in various cellular events has been investi- 
gated using wortmannin, a highly specific inhibitor of PI3K [1]. 
Recently, wortmannin has been shown to inhibit the sorting of 
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a newly made mammalian lysosomal enzyme (cathepsin D) 
from the TGN to endosomes and lysosomes, which are the 
mammalian equivalent of vacuoles [5,6]. Instead, the cathepsin 
D was efficiently secreted from the mammalian cells. This pro- 
vided strong evidence that PI3K plays a similar role in sorting 
of lysosomal enzymes in both yeast and mammalian cells. 
In polarized epithelial cells, sorting in the endosomal system 
plays a role the establishment and maintenance ofcell polarity 
[7,8]. The plasma membrane of these cells contains an apical 
surface, which faces the lumen of an organ or gland, and a 
basolateral surface, facing other cells and connective tissue. The 
apical and basolateral plasma membranes have very different 
protein and lipid compositions. After endocytosis from either 
surface, a protein has at least three choices: recycling to the 
original plasma membranedomain, transfer to late endosomes 
and lysosomes, or transcytosis tothe opposite surface. Transcy- 
tosis has at least two main functions [7]. First, many newly 
made proteins that will become permanent residents of the 
apical surface are delivered first to the basolateral surface, and 
then endocytosed and transcytosed to the apical surface. 
Transcytosis i the only route for delivery of membrane pro- 
teins to the apical surface that is universally found in all epithe- 
lial cells so far examined, and in some cells is the only route for 
delivery of membrane proteins to that surface. 
Second, extracellular ligands can bind to a receptor at one 
surface and then be transcytosed to the opposite surface. The 
best studied example of ligand transcytosis the transcytosis 
of dimeric IgA (dlgA) by the polymeric immunoglobulin recep- 
tor (plgR) in many mucosal epithelial cells [9]. The plgR is sent 
from the TGN to the basolateral surface, where it can bind 
dlgA. The plgR is then endocytosed and delivered to baso- 
lateral early endosomes. The plgR then passes through a spe- 
cialized endosomal compartment, known as the apical recycling 
endosome, before finally being delivered to the apical surface. 
At the apical surface the extracellular, ligand binding domain 
of the plgR is cleaved and released together with the dlgA into 
external secretions. This cleaved fragment is called secretory 
component. The transcytosed dlgA forms the first specific im- 
munological defense against mucosal infectious agents. Tran- 
scytosis of dlgA is thus a key step in the mucosal immune 
response. 
Like lysosomal enzyme sorting, transcytosis  a good model 
in which to study regulation of traffic in the endosomal system. 
Transcytosis of the plgR is regulated by ligand binding and by 
several intracellular signaling pathways, including protein ki- 
nase C, the heterotrimeric Gs protein, cAMP, and protein ki- 
nase A [7,10]. Here we have used wortmannin to investigate a 
possible role for PI3K in regulation of transcytosis of plgR and 
dlgA. 
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2. Materials and methods 
Virtually all of the procedures used, such as culture of MDCK cells 
expressing pIgR on Transwell filters, and the assay for transcytosis and 
recycling of radio-iodinated dIgA, were performed as described [10]. In 
ou: standard assay of transcytosis cells were allowed to internalize a 
cohort of radio-iodinated dlgA from the basolateral surface for 15 rain, 
w;~shed for 5 rain, and delivery into the apical medium (transcytosis) 
ot basolateral medium (recycling) was followed for 2 h. Transcytosis 
ar d recycling are expressed as a percentage of the total dlgA in all 
fr, ctions, including remaining associated with the cells and filters at the 
er t of the assay. Wortmannin was purchased from Kamiya Biochemi- 
ca s, Thousand Oaks, CA and made up as a stock solution of l mM 
in DMSO. Wortmannin was included at the indicated concentrations 
in all steps, starting with the 15 rain uptake. DMSO alone had no effect. 
3. Results and discussion 
As in our previous studies, we used MDCK cells that had 
b~en transfected with the cDNA for rabbit pIgR [10]. These 
cc[ls were grown on permeable filter supports to form a tight 
m 3nolayer. We have previously described an assay for transcy- 
tc,sis and recycling of a dIgA by the pIgR expressed in these 
ct lls. Cells were allowed to internalize a cohort of radio-iodi- 
n;,,ted dIgA from the basolateral surface. The transcytosis of 
this dlgA into the medium overlying the apical surface of the 
cells was then measured. Treatment of the cells with wortman- 
n,n resulted in a partial inhibition of transcytosis of the dlgA 
(t'ig. 1). Inhibition of transcytosis increased with increasing 
c, ,ncentration of wortmannin. The inhibition was most dra- 
ntatic at earlier time points. Even the lowest dose utilized, 250 
n'vI wortmannin, gave an approximately 75% inhibition of 
t] anscytosis at the earliest ime point, 7.5 min. At later time 
p~ints the inhibition was somewhat less, suggesting that the 
ei fect of wortmannin was to a considerable extent on the kinet- 
it ~ of transcytosis. However, even with 250 nM wortmannin the 
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tig. 1. Effect of wortmannin on transcytosis. Wortmannin was added 
a the indicated concentration. Transcytosis ofa preinternalized cohort 
e" radio-iodinated dIgA into the apical medium was measured over a 
2 h time course. Data are means of 3 or 4 determinations. For clarity, 
error bars are not shown, but standard errors were less than 10% of the 
x alue. 
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Fig. 2. Effect of wortmannin on recycling. Cells were either untreated 
or treated with 1 ~M wortmannin. Recycling of a pre-internalized 
cohort of radio-iodinated dIgA into the basal medium was measured 
over a 2 h time course. Error bars are standard errors of 3 or 4 
determinations. 
extent of transcytosis during the complete 2 h time course of 
the assay was significantly reduced. 
As previously described, in the absence of wortmannin, 
about 20% of the dIgA recycles back to the basolateral medium 
[10,12]. However, in the presence of I j2M wortmannin, recy- 
cling of dIgA to the basolateral medium was significantly in- 
creased (Fig. 2). The increase in recycling largely complemented 
the decrease in transcytosis, uggesting that the dIgA was redi- 
rected by the drug from the transcytotic to the recycling path- 
way. In all cases, degradation of dIgA was less then 5% of the 
total material, indicating that the dIgA was not mistargeted 
into the lysosomal pathway. Wortmannin did not alter the 
permeability characteristics of the tight MDCK monlayer, so 
our results were not an effect of dlgA leaking across the 
monolayer (not shown). 
The total amount of dIgA internalized by the cells during the 
uptake period was not significantly affected by wortmannin 
(not shown), suggesting that initial delivery of pIgR from the 
TGN to the basolateral surface and endocytosis were not af- 
fected. This is in agreement with other studies that transport 
through the entire secretory pathway from the rough endoplas- 
mic reticulum through the Golgi to the cell surface, as well as 
the actual step of internalization at the cell surface, are not 
affected by wortmannin [5,6]. Endocytosis of the platelet-de- 
rived growth factor is inhibited when the interaction of this 
receptor with PI3K is blocked [11,12]. However, this receptor 
is auto-phosphorylated on tyrosine residues, and thereby binds 
to an SH2 domain-containing PI3K. In contrast, the pIgR is 
not a tyrosine kinase and is not itself phosphorylated on tyro- 
sine. Therefore it is highly unlikely that the pIgR interacts with 
a PI3K via an SH2 domain. The involvement of PI3K in traf- 
ficking of the pIgR is probably quite different from the role of 
PI3K in internalization of the platelet derived growth factor 
receptor. 
In addition to its role in lysosomal enzyme trafficking, PI3K 
appears to play roles in antigen presentation [13], delivery of 
factor to the yeast vacuole [14,15], insulin stimulated recruit- 
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ment of transferrin receptors and glucose transporters to the 
plasma membrane [16,17], sorting of lysosomal membrane 
glycoproteins (B. Reaves, pers. comm.) and several other proc- 
esses [1]. Our results strongly suggest that PI3K plays a novel 
role in endosomal traffic in polarized epithelial cells, i.e. in 
transcytosis of pIgR from the basolateral to the apical surface. 
We do not know how this is related to the role of P13K in 
delivery of lysosomal enzymes, but it may reflect some common 
underlying function of PI3K in regulating traffic in the en- 
dosomal system. In certain epithelial cells, such as Caco2 cells, 
high levels of lysosomal enzymes are found at the apical surface 
and in endosomes immediately underlying the apical surface 
[18], which may be related to the apical recycling endosomes 
through which pIgR passes on its way to the apical surface [19]. 
It is therefore plausible that delivery to the apical recycling 
compartment and/or apical plasma membrane have some as- 
pects in common with delivery of lysosomal enzymes to lyso- 
somes, including a similar role for PI3K. A more general hy- 
pothesis might be that many of the effects of wortmannin result 
from blocking exit of materials from endosomes, or at least 
certain pathways out of particular endosomal subcompart- 
ments. In the case of transcytosis, this might be on exit from 
some portion of the endosomal system into the transcytotic 
pathway. 
In addition to VPS34 in yeast, at least four species of PI3K 
have been found in mammalian cells [1,20-26]. These differ in 
their susceptibility o wortmannin, and in their tissue and cell 
type distribution. Although some types of PI3K are inhibited 
by concentrations of wortmannin in the low nanomolar range, 
at least one type of PI3K (i.e. VPS34) requires a low micromo- 
lar concentration of wortmannin to be inhibited. For instance, 
sorting of cathepsin D in CHO or NRK cells required 1-3 tiM 
wortmannin to demonstrate strong inhibition [6]. This is similar 
to the concentration range used here, suggesting that the PI3K 
involved in transcytosis of pIgR may be related to the PI3K 
involved in cathepsin D sorting in CHO or NRK cells. 
Especially at concentrations at or above the low micromolar 
range, wortmannin can inhibit other enzymes, such as 
phosphatidylinositol 4-kinase, or protein kinases [1]. In the 
study using 1-3/tM wortmannin to inhibit cathepsin D sorting, 
it was concluded that the effect of wortmannin was specifically 
on PI3K, and not on some other enzyme [6]. It has previously 
been shown that both wide-spectrum inhibitors of protein ki- 
nases, such as staurospaurine, as well as more specific inhib- 
itors of protein kinase C (e.g, H7) or of protein kinase A (e.g. 
H89), do not inhibit pIgR transcytosis [10,27]. Transcytosis of 
pIgR without dIgA bound depends on phosphorylation f the 
plgR itself at Ser-664 [28]. Mutation of Ser-664 to Ala reduces 
transcytosis of pIgR molecules that do not have dIgA bound. 
However, dIgA bound to pIgR is transcytosed efficiently even 
in the absence of phosphorylation of residue 664 [29]. In the 
present study we measured the transcytosis of dIgA bound to 
plgR, so it is quite unlikely that wortmannin exerts its effects 
by inhibiting phosphorylation f Ser-664. 
The effects of wortmannin are strikingly similar to our previ- 
ous observations on the effects of drugs that specifically inhibit 
calmodulin, such as W13 [30]. Both wortmannin and W13 
block transcytosis of dlgA in a dose-dependent fashion and 
correspondingly increase recycling. It will be interesting to de- 
termine if calmodulin and PI3K work in the same pathway to 
regulate transcytosis and other membrane traffic events. 
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